Cancer drugs among 33 life-saving medicines set to get cheaper after GST rate cut. Full list
According to a release by the Press Information Bureau, the GST rate for "all other drugs and medicines" has been brought down from 12 percent to 5 percent.
The GST Council, chaired by union finance minister Nirmala Sitharaman, approved a sweeping rationalisation of GST rates to help ease the costs for the common man in key areas like household items and critical healthcare.

In a major boost to public health, the Council recommended a reduction of GST from 12 percent to nil on 33 lifesaving drugs, and from 5 percent to nil on three critical drugs used for cancer, rare diseases and other severe chronic illnesses. According to a release by the Press Information Bureau, the GST rate for "all other drugs and medicines" has been brought down from 12 percent to 5 percent, while many medical devices and diagnostic kits will also fall under a lower tax bracket. The new rates will kick in on September 22, the first day of Navratri.
Complete List Of The 33 Lifesaving Drugs which will attract nil tax
The complete list of lifesaving drugs that the GST Council has slashed tax is as follows, according to the PIB release:
- Agalsidase Beta
- Imiglucerase
- Eptacog alfa (activated recombinant coagulation factor VIIa)
- Onasemnogene abeparvovec
- Asciminib
- Mepolizumab
- Pegylated Liposomal Irinotecan
- Daratumumab (including subcutaneous)
- Teclistamab
- Amivantamab
- Alectinib
- Risdiplam
- Obinutuzumab
- Polatuzumab vedotin
- Entrectinib
- Atezolizumab
- Spesolimab
- Velaglucerase Alpha
- Agalsidase Alfa
- Rurioctocog Alpha Pegol
- Idursulphatase
- Alglucosidase Alfa
- Laronidase
- Olipudase Alfa
- Tepotinib
- Avelumab
- Emicizumab
- Belumosudil
- Miglustat;
- Velmanase Alfa
- Alirocumab
- Evolocumab
- Cystamine Bitartrate
- CI-Inhibitor injection
- Inclisiran. (See PIB annexure for exact HSN mappings and the authoritative list.)
ABOUT THE AUTHORHT News DeskFollow the latest breaking news, major developments and agenda-setting stories from India and around the world with the newsdesk at Hindustan Times. Operating round the clock, the desk brings together experienced editors, reporters and correspondents to deliver fast, accurate and contextual reporting across subjects that influence public policy, governance, business, society and international affairs. The HT News Desk covers politics, elections, government policies, the economy, business and markets, science and technology, the environment, law and order, infrastructure, education, climate issues and geopolitics, while closely tracking developments across states, institutions and global capitals. The team also leads coverage of major breaking news events, policy announcements, court proceedings, natural disasters, public emergencies and significant international developments. Reports published by the newsdesk are based on information gathered from reporters on the ground, official statements, government agencies, court records, regulatory filings, recognised institutions and other authoritative sources. Stories undergo editorial scrutiny and verification processes to ensure accuracy, fairness and relevance, and are updated as events evolve and additional information becomes available. Whether covering a key political decision in New Delhi, an economic policy shift affecting millions, a landmark court ruling or a major global event, the HT News Desk aims to provide readers with reliable, fact-based journalism that delivers not only the latest developments but also the context and analysis needed to understand their wider implications.Read More

E-Paper


